Identification and Characterization of Sebaceous Gland Atrophy-Sparing DGAT1 Inhibitors

Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial

(2013) H. Denison et al.   DIABETES OBESITY & METABOLISM

A practical guide for the study of human and murine sebaceous glandsin situ

(2013) Eleanor Hinde et al.   EXPERIMENTAL DERMATOLOGY

Current Status of the Research and Development of Diacylglycerol O-Acyltransferase 1 (DGAT1) Inhibitors

(2013) Robert J. DeVita et al.   JOURNAL OF MEDICINAL CHEMISTRY

Diacylglycerol Acyltransferase-1 (DGAT1) Inhibition Perturbs Postprandial Gut Hormone Release

(2013) Hua V. Lin et al.   PLoS One

Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study

(2012) H. Denison et al.   DIABETES OBESITY & METABOLISM

Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases

(2011) Jingsong Cao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of Nine Programs Predicting pKaValues of Pharmaceutical Substances

(2009) Chenzhong Liao et al.   Journal of Chemical Information and Modeling

Role of the Molybdoflavoenzyme Aldehyde Oxidase Homolog 2 in the Biosynthesis of Retinoic Acid: Generation and Characterization of a Knockout Mouse

(2008) M. Terao et al.   MOLECULAR AND CELLULAR BIOLOGY